Skip to content
HowShorted

Hims & Hers Health, Inc. short interest in 2022

In 2022, Hims & Hers Health, Inc.'s disclosed short interest ran from 3.80% of shares outstanding on 14 Jan 2022 to 7.78% on 30 Dec 2022, a change of +3.98 percentage points. The year's high was 7.92% on 30 Nov 2022 and its low 3.80% on 14 Jan 2022, averaging 5.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.28 days on 30 Dec 2022. Full history: Hims & Hers Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Hims & Hers Health, Inc. in 2022

2022 in figures

Start of year
3.80% (14 Jan 2022)
End of year
7.78% (30 Dec 2022)
Change
+3.98 pp
High
7.92% (30 Nov 2022)
Low
3.80% (14 Jan 2022)
Average
5.64%
Highest days to cover
14.28 (30 Dec 2022)
SEC filings marked
8

Every report in 2022

Hims & Hers Health, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20223.80%3.96
31 Jan 20224.00%3.09
15 Feb 20224.81%4.90
28 Feb 20225.05%2.98results (8-K), 10-K filed
15 Mar 20224.35%3.30
31 Mar 20224.00%4.03
14 Apr 20223.92%4.43
29 Apr 20224.23%5.57
13 May 20224.72%3.1210-Q filed, results (8-K)
31 May 20224.36%4.11
15 Jun 20224.50%5.44
30 Jun 20225.72%3.21
15 Jul 20225.97%6.44
29 Jul 20226.03%8.00
15 Aug 20226.39%5.7710-Q filed, results (8-K)
31 Aug 20226.44%9.79
15 Sep 20226.58%9.41
30 Sep 20226.31%11.12
14 Oct 20226.73%9.80
31 Oct 20226.36%8.13
15 Nov 20227.69%5.0210-Q filed, results (8-K)
30 Nov 20227.92%10.60
15 Dec 20227.78%9.90
30 Dec 20227.78%14.28

See also: Hims & Hers Health, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.